OR WAIT null SECS
Rolf Ehrhardt, MD, PhD is CEO of MedCision.
October 01, 2017
Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
July 14, 2017
In this article, MedCision executive discusses cell therapies.